Evidence map›Paper›PMID 38893262›Full record

ArticleCancers2024

Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis.

Nishita Tripathi, Georges Gebrael, Beverly Chigarira, Kamal Kant Sahu, Ishwarya Balasubramanian, Constance Caparas, Vinay Mathew Thomas, Jessica N Cohan, Kaitlyn Pelletier, Benjamin L Maughan and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nishita TripathiHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Georges GebraelHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0002-4085-6415
Beverly ChigariraHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Kamal Kant SahuHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0002-0382-6882
Ishwarya BalasubramanianHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Constance CaparasHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Vinay Mathew ThomasHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0001-9916-730X
Jessica N CohanHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Kaitlyn PelletierHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Benjamin L MaughanHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Neeraj AgarwalHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0003-1076-0428
Umang SwamiHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0003-3518-0411
Sumati GuptaHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0001-6271-0831

Funding

Targeting ARID1A mutated Urothelial CarcinomaI01BX005765 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI Sumati Gupta · 2024 to 2026
–
BLRD VA I01 BX005765This study is supported by a grant to Sumati Gupta from the NCCN/Pfizer. Sumati 389 Gupta is also supported by a VA merit grant from VHA BX005765- 01A
6 · The paper itself

Abstract

Metastatic urinary tract cancer (mUTC) is challenging to treat in older adults due to comorbidities. We compared the clinical courses of younger and older (≥70 years) adults with mUTC receiving first-line (1L) systemic therapy in a tertiary cancer center. Baseline clinical characteristics, treatments received, tolerability, and survival outcomes were analyzed. Among 212 patients (103 older vs. 109 younger), the older patients had lower hemoglobin at baseline (84% vs. 71%,

Indexed as

chemotherapygeriatric patientsimmunotherapymetastatic bladder cancerolder adultsurothelial carcinomayounger adults

Identifiers

PMID38893262
PMCPMC11172373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.